Foxo Technologies Inc
AMEX:FOXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (24.5), the stock would be worth $-0 (2 568% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1 | $0 |
0%
|
| Industry Average | 24.5 | $-0 |
-2 568%
|
| Country Average | 19.6 | $-0 |
-2 077%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Foxo Technologies Inc
AMEX:FOXO
|
249.6k USD | -1 | -0 | |
| US |
|
Ezenia! Inc
OTC:EZEN
|
567B USD | -177 298 | -180 630.8 | |
| US |
|
Palantir Technologies Inc
NASDAQ:PLTR
|
337.4B USD | 233.2 | 207.2 | |
| DE |
|
SAP SE
XETRA:SAP
|
164.1B EUR | 16.3 | 23.5 | |
| US |
|
Salesforce Inc
NYSE:CRM
|
162.4B USD | 18.3 | 21.8 | |
| US |
|
Applovin Corp
NASDAQ:APP
|
153.7B USD | 37.3 | 46.1 | |
| US |
|
Intuit Inc
NASDAQ:INTU
|
106.4B USD | 19.8 | 24.5 | |
| US |
|
Adobe Inc
NASDAQ:ADBE
|
97B USD | 10.6 | 13.5 | |
| US |
N
|
NCR Corp
LSE:0K45
|
86.7B USD | 604.2 | 2 065.2 | |
| US |
|
Synopsys Inc
NASDAQ:SNPS
|
87.5B USD | 96.8 | 79.4 | |
| US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
85.4B USD | 51.1 | 77 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Foxo Technologies Inc
Glance View
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.
